Arginine

isocitrate dehydrogenase (NADP(+)) 1 ; Homo sapiens







34 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31199148 Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. 2019 Jul 25 2
2 29303363 Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma. 2018 Jan 1
3 29382206 TOF-SIMS analysis of an isocitrate dehydrogenase 1 mutation-associated oncometabolite in cancer cells. 2018 Jan 30 1
4 29670690 Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers. 2018 Apr 12 1
5 29743236 IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53. 2018 Jun 22 1
6 30194083 Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas. 2018 Sep-Oct 1
7 27406240 Point mutation (R153H or R153C) in Escherichia coli isocitrate dehydrogenase: Biochemical characterization and functional implication. 2017 Jan 2
8 26188014 Isocitrate dehydrogenase mutations in gliomas. 2016 Jan 1
9 26967252 Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. 2016 Apr 12 1
10 27956631 The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development. 2016 Dec 27 2
11 25324168 Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas. 2015 Jan 3
12 25787993 Isocitrate dehydrogenase mutations: new opportunities for translational research. 2015 May 1
13 25853107 Identification of a new selective chemical inhibitor of mutant isocitrate dehydrogenase-1. 2015 Mar 3
14 26147657 Role of isocitrate dehydrogenase 1/2 (IDH 1/2) gene mutations in human tumors. 2015 Oct 2
15 26198745 Glandular differentiation in dedifferentiated chondrosarcoma: molecular evidence of a rare phenomenon. 2015 Sep 1
16 23235339 Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas. 2014 Apr 1
17 24590270 Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation. 2014 Jun 1
18 24626950 Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner. 2014 May 2
19 24898068 Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. 2014 Jun 4
20 23264629 The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. 2013 Feb 8 3
21 21996744 Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production. 2012 May 10 1
22 22238332 Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. 2012 Jan 11 1
23 22396072 Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. 2012 Jul 2
24 22442146 Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation. 2012 Apr 27 1
25 22809434 Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia. 2012 Aug 1
26 22904127 IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. 2012 Aug 1
27 23090985 Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. 2012 Dec 1
28 23267435 Promoter Methylation Analysis of IDH Genes in Human Gliomas. 2012 1
29 21352804 Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation. 2011 Mar 25 2
30 21647154 IDH1 and IDH2 mutations in pediatric acute leukemia. 2011 Oct 1
31 20142433 Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. 2010 Feb 15 1
32 20513808 Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. 2010 Jul 7 1
33 20692206 IDH mutations in glioma and acute myeloid leukemia. 2010 Sep 1
34 23905201 ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells 2010 1